BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help

Search Results

Documents 1-25 out of over 1000 found
  Current Search:  cap: 1589     

HTML
100%
5-Star Stocks Poised to Pop: ISTA Pharmaceuticals
Based on the aggregated intelligence of 150,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, ophthalmic drug company ISTA Pharmaceuticals (Nasdaq: ISTA) has earned a coveted five-star ranking.

With that in mind,...

Motley Fool:  Feb 9 2010 3:37PM
Matching: cap
Find similar documents
HTML
100%
5-Star Stocks Poised to Pop: ISTA Pharmaceuticals
Based on the aggregated intelligence of 150,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, ophthalmic drug company ISTA Pharmaceuticals (Nasdaq: ISTA) has earned a coveted five-star ranking.

With that in mind,...

Motley Fool via MSN Money:  Feb 9 2010 3:22PM
Matching: cap
Find similar documents
HTML
100%
Agendia Receives New York State Laboratory Permit and Laboratory Accreditation by College of American Patholog
HUNTINGTON BEACH, California With this latest permit, Agendia has now obtained all major U.S.

clinical laboratory licenses.

In addition, the College of American Pathologists (CAP) has accredited Agendia's CLIA regulated laboratory in Huntington Beach,...

Therapeutics Daily:  Feb 9 2010 3:52PM
Matching: cap
Find similar documents
HTML
100%
Agendia Receives New York State Laboratory Permit and Laboratory Accreditation by College of American Patholog
Companies mentioned in this article: Agendia B.V.

HUNTINGTON BEACH, California and AMSTERDAM, February 9 /PRNewswire/ -- Agendia, a world leader in molecular cancer diagnostics, announced today that it has received the Clinical Laboratory Permit from the New...

Freshnews.com:  Feb 9 2010 2:21PM
Matching: cap
Find similar documents
HTML
100%
Sensex closes above 16k; IT, pharma, cement, banks gain
The benchmark Sensex closed above the psychological 16000 mark for the first time in the last four sessions on the back of buying interest in technology, cement, pharma, banking, select telecom and capital goods.

Positive global cues also helped the markets....

Moneycontrol.com:  Feb 9 2010 1:34PM
Matching: cap
Find similar documents
HTML
100%
Large cap pharma space going up on negative diversions: Shardul Kulkarni
Shardul Kulkarni , Senior Technical Analyst, Angel Broking, in an interview with ET Now says, most of the large cap pharma space that has been going up on negative diversions.

Excerpts: Q: We have spoken about the midcap pharma pack, we have spoken...

Economictimes:  Feb 9 2010 7:10PM
Matching: cap
Find similar documents
HTML
100%
Liberty Analytics Co. Initiates Independent Research Coverage on NexMed, Inc
CALGARY, Alberta, Feb.

9, 2010 (GLOBE NEWSWIRE) -- Liberty Analytics Co., a leading provider of large, small - and micro-cap independent investment research, today initiated coverage on NexMed, Inc.

Liberty Analytics is currently offering a...

Interest!ALERT:  Feb 9 2010 5:31PM
Matching: cap
Find similar documents
HTML
100%
Some Small-Cap Biotech Stocks Worth Watching
Garza Send Message You are currently following M.

Garza Stop Following You are no longer following M.

Garza About this author: Profile & More Articles Visit: BioMedReports.Com Submit an article to Font Size: Print Email There are a number of stocks we...

Seeking Alpha:  Feb 9 2010 4:17PM
Matching: cap
Find similar documents
HTML
100%
Sequenom Licenses Worldwide Rights to Develop Age-Related Macular Degeneration Diagnostic Test
SAN DIEGO, Feb.

9 /PRNewswire-FirstCall/ -- Sequenom, Inc.

(Nasdaq: SQNM), today announced an exclusive worldwide licensing agreement with Optherion, Inc.

Under the agreement, Sequenom's CAP accredited and CLIA-certified laboratory, Sequenom Center...

Charlotte Business Journal:  Feb 9 2010 3:24PM
Matching: cap
Find similar documents
HTML
100%
Sequenom Licenses Worldwide Rights to Develop Age-Related Macular Degeneration Diagnostic Test
SAN DIEGO, Feb.

9 /PRNewswire-FirstCall/ -- Sequenom, Inc.

(Nasdaq: SQNM), today announced an exclusive worldwide licensing agreement with Optherion, Inc.

Under the agreement, Sequenom's CAP accredited and CLIA-certified laboratory, Sequenom Center...

Denver Business Journal:  Feb 9 2010 3:24PM
Matching: cap
Find similar documents
HTML
100%
Sequenom Licenses Worldwide Rights to Develop Age-Related Macular Degeneration Diagnostic Test
SAN DIEGO, Feb.

9 /PRNewswire-FirstCall/ -- Sequenom, Inc.

(Nasdaq: SQNM), today announced an exclusive worldwide licensing agreement with Optherion, Inc.

Under the agreement, Sequenom's CAP accredited and CLIA-certified laboratory, Sequenom Center...

St Louis Business Journal:  Feb 9 2010 3:24PM
Matching: cap
Find similar documents
HTML
100%
Sequenom Licenses Worldwide Rights to Develop Age-Related Macular Degeneration Diagnostic Test
SAN DIEGO, Feb.

9 /PRNewswire-FirstCall/ -- Sequenom, Inc.

(Nasdaq: SQNM), today announced an exclusive worldwide licensing agreement with Optherion, Inc.

Under the agreement, Sequenom's CAP accredited and CLIA-certified laboratory, Sequenom Center...

Birmingham Business Journal:  Feb 9 2010 3:23PM
Matching: cap
Find similar documents
HTML
100%
Sequenom Licenses Worldwide Rights to Develop Age-Related Macular Degeneration Diagnostic Test
SAN DIEGO, Feb.

9 /PRNewswire-FirstCall/ -- Sequenom, Inc.

(Nasdaq: SQNM), today announced an exclusive worldwide licensing agreement with Optherion, Inc.

Under the agreement, Sequenom's CAP accredited and CLIA-certified laboratory, Sequenom Center...

Kansas City Business Journal:  Feb 9 2010 3:22PM
Matching: cap
Find similar documents
HTML
100%
Sequenom Licenses Worldwide Rights to Develop Age-Related Macular Degeneration Diagnostic Test
SAN DIEGO, Feb.

9 /PRNewswire-FirstCall/ -- Sequenom, Inc.

(Nasdaq: SQNM), today announced an exclusive worldwide licensing agreement with Optherion, Inc.

Under the agreement, Sequenom's CAP accredited and CLIA-certified laboratory, Sequenom Center...

Dallas Business Chronicle:  Feb 9 2010 3:20PM
Matching: cap
Find similar documents
HTML
100%
Sequenom Licenses Worldwide Rights to Develop Age-Related Macular Degeneration Diagnostic Test
SAN DIEGO, Feb.

9 /PRNewswire-FirstCall/ -- Sequenom, Inc.

(Nasdaq: SQNM), today announced an exclusive worldwide licensing agreement with Optherion, Inc.

Under the agreement, Sequenom's CAP accredited and CLIA-certified laboratory, Sequenom Center...

Houston Business Journal:  Feb 9 2010 3:16PM
Matching: cap
Find similar documents
HTML
100%
Sequenom Licenses Worldwide Rights to Develop Age-Related Macular Degeneration Diagnostic Test
SAN DIEGO, Feb.

9 /PRNewswire-FirstCall/ -- Sequenom, Inc.

(Nasdaq: SQNM), today announced an exclusive worldwide licensing agreement with Optherion, Inc.

Under the agreement, Sequenom's CAP accredited and CLIA-certified laboratory, Sequenom Center...

San Francisco Business Times:  Feb 9 2010 3:16PM
Matching: cap
Find similar documents
HTML
100%
Sequenom Licenses Worldwide Rights to Develop Age-Related Macular Degeneration Diagnostic Test
SAN DIEGO, Feb.

9 /PRNewswire-FirstCall/ -- Sequenom, Inc.

(Nasdaq: SQNM), today announced an exclusive worldwide licensing agreement with Optherion, Inc.

Under the agreement, Sequenom's CAP accredited and CLIA-certified laboratory, Sequenom Center...

Portland Business Journal:  Feb 9 2010 3:16PM
Matching: cap
Find similar documents
HTML
100%
Sequenom Licenses Worldwide Rights to Develop Age-Related Macular Degeneration Diagnostic Test
SAN DIEGO, Feb.

9 /PRNewswire-FirstCall/ -- Sequenom, Inc.

(Nasdaq: SQNM), today announced an exclusive worldwide licensing agreement with Optherion, Inc.

Under the agreement, Sequenom's CAP accredited and CLIA-certified laboratory, Sequenom Center...

Wichita Business Journal:  Feb 9 2010 3:15PM
Matching: cap
Find similar documents
HTML
100%
Sequenom Licenses Worldwide Rights to Develop Age-Related Macular Degeneration Diagnostic Test
SAN DIEGO, Feb.

9 /PRNewswire-FirstCall/ -- Sequenom, Inc.

(Nasdaq: SQNM), today announced an exclusive worldwide licensing agreement with Optherion, Inc.

Under the agreement, Sequenom's CAP accredited and CLIA-certified laboratory, Sequenom Center...

Sacramento Business Journal:  Feb 9 2010 3:14PM
Matching: cap
Find similar documents
HTML
100%
Sequenom Licenses Worldwide Rights to Develop Age-Related Macular Degeneration Diagnostic Test
SAN DIEGO, Feb.

9 /PRNewswire-FirstCall/ -- Sequenom, Inc.

(Nasdaq: SQNM), today announced an exclusive worldwide licensing agreement with Optherion, Inc.

Under the agreement, Sequenom's CAP accredited and CLIA-certified laboratory, Sequenom Center...

Cincinnati Business Journal:  Feb 9 2010 3:11PM
Matching: cap
Find similar documents
HTML
100%
Sequenom Licenses Worldwide Rights to Develop Age-Related Macular Degeneration Diagnostic Test
SAN DIEGO, Feb.

9 /PRNewswire-FirstCall/ -- Sequenom, Inc.

(Nasdaq: SQNM), today announced an exclusive worldwide licensing agreement with Optherion, Inc.

Under the agreement, Sequenom's CAP accredited and CLIA-certified laboratory, Sequenom Center...

Pittsburgh Business Times:  Feb 9 2010 2:56PM
Matching: cap
Find similar documents
HTML
100%
Sequenom Licenses Worldwide Rights to Develop Age-Related Macular Degeneration Diagnostic Test
SAN DIEGO, Feb.

9 /PRNewswire-FirstCall/ -- Sequenom, Inc.

(Nasdaq: SQNM), today announced an exclusive worldwide licensing agreement with Optherion, Inc.

Under the agreement, Sequenom's CAP accredited and CLIA-certified laboratory, Sequenom Center...

Twin Cities Business Journal:  Feb 9 2010 2:52PM
Matching: cap
Find similar documents
HTML
100%
Sequenom Licenses Worldwide Rights to Develop Age-Related Macular Degeneration Diagnostic Test
SAN DIEGO, Feb.

9 /PRNewswire-FirstCall/ -- Sequenom, Inc.

(Nasdaq: SQNM), today announced an exclusive worldwide licensing agreement with Optherion, Inc.

Under the agreement, Sequenom's CAP accredited and CLIA-certified laboratory, Sequenom Center...

Baltimore Business Journal:  Feb 9 2010 2:51PM
Matching: cap
Find similar documents
HTML
100%
Sequenom Licenses Worldwide Rights to Develop Age-Related Macular Degeneration Diagnostic Test
SAN DIEGO, Feb.

9 /PRNewswire-FirstCall/ -- Sequenom, Inc.

(Nasdaq: SQNM), today announced an exclusive worldwide licensing agreement with Optherion, Inc.

Under the agreement, Sequenom's CAP accredited and CLIA-certified laboratory, Sequenom Center...

Forbes.com:  Feb 9 2010 2:44PM
Matching: cap
Find similar documents
HTML
100%
Sequenom Licenses Worldwide Rights to Develop Age-Related Macular Degeneration Diagnostic Test
SAN DIEGO, Feb.

9 /PRNewswire-FirstCall/ -- Sequenom, Inc.

(Nasdaq: SQNM), today announced an exclusive worldwide licensing agreement with Optherion, Inc.

Under the agreement, Sequenom's CAP accredited and CLIA-certified laboratory, Sequenom Center...

Columbus Business First:  Feb 9 2010 2:44PM
Matching: cap
Find similar documents


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.